Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    MDVN

Delayed Quote. Delayed  - 02/12 03:59:59 pm
30.44 USD   +6.51%
02/11 MEDIVATION : Announces Fourth Quarter and Year-End 2015 Financial Re..
01/27 MEDIVATION : to Present at Leerink Partners 5th Annual Global Health..
01/26 MEDIVATION : Journal of Clinical Oncology Publishes Results from the..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

10/30/2013 | 04:34pm US/Eastern

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
React to this article
Latest news on MEDIVATION INC
02/11 MEDIVATION : Announces Fourth Quarter and Year-End 2015 Financial Results Teleco..
02/09 MEDIVATION : Establishment Labs Announces the Appointment of Dr. David Hung to I..
02/04 ASTELLAS PHARMA : Journal of Clinical Oncology Publishes Results from the STRIVE..
01/29 MEDIVATION : Regulation FD Disclosure (form 8-K)
01/27 MEDIVATION : to Present at Leerink Partners 5th Annual Global Healthcare Confere..
01/26 MEDIVATION : Journal of Clinical Oncology Publishes Results from the STRIVE tria..
01/26 MEDIVATION : Journal of Clinical Oncology Publishes Results From the STRIVE Tria..
01/25 MEDIVATION : Partners Eye Companion Diagnostics Market
01/25 MEDIVATION : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
01/13 MEDIVATION : Lancet Oncology Publishes Results from the Phase 2 TERRAIN Trial of..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials